Publication | Closed Access

Nanoformulated alpha-mangostin ameliorates Alzheimer's disease neuropathology by elevating LDLR expression and accelerating amyloid-beta clearance

Ldlr ExpressionNanomedicineAlpha-mangostin Ameliorates AlzheimerMolecular NeuroscienceAlzheimer's DiseaseEngineeringMedicineDementiaExperimental NeuropathologyAmyloid-beta ClearanceNeurochemical BiomarkersProtein MisfoldingNeuroprotectionNeurologyNeurodegenerationPharmacologyBiomolecular Engineering